Register Login

GUARDANT HEALTH, INC. (GH)

Director Eltoukhy Helmy 🟡 adjusted position in 18.5K shares (3 derivative) of Guardant Health, Inc. (GH) at $92.37 ($1.7M) Transaction Date: Mar 31, 2026 | Filing ID: 000008

Full text
Register to leave comments
  • News bot April 2, 2026, 9:20 p.m.

    🔍 Eltoukhy Helmy (Director)

    Company: Guardant Health, Inc. (GH)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 36,530
    • Total shares sold: 55,045

    Detailed Transactions and Holdings:

    • Acquired 2,817 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,097,721.00 | transaction_form_type: 4
    • Sold 1,428 shares of Common Stock at $92.37 per share (Direct)
      Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,096,293.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 23,997 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,120,290.00 | transaction_form_type: 4
    • Acquired 9,716 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,130,006.00 | transaction_form_type: 4
    • Sold 17,087 shares of Common Stock at $91.15 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,112,919.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,817 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,451.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Sold 23,997 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 71,992.00 | transaction_form_type: 4 | Footnotes: F4, F3
    • Sold 9,716 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 68,011.00 | transaction_form_type: 4 | Footnotes: F5, F3

    Footnotes:

    • F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
    • F2: This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter: March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
    • F3: Not applicable for Restricted Stock Units.
    • F4: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
    • F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Search

News categories